Patient no. | Sex | Age (y) | Diagnosis | Previous therapy | Administered activity (GBq) | PRRT | BM | Latency period (mo) | ||
Interrupted | Protocol | Cytopenia | Diagnosis | |||||||
359 | F | 70 | NET | Cold octreotide | 30.0 | No | On | Hb | MDS, RARS | 42.4 |
297 | F | 60 | NET | Cold octreotide | 18.6 | Yes, maximum kidney dose | On | Hb, PLT, WBC | Hypoplasia | 36.3 |
293 | M | 61 | PNET | Chemoembolization | 29.3 | No | On | Hb, PLT | CML | 42.3 |
284 | M | 57 | PNET | — | 29.7 | No | On | Hb | MDS, RAEB-II | 33.3 |
252 | F | 64 | NET | Cold octreotide | 30.0 | No | On | Hb, WBC | Pancytopenia | 45.7 |
241 | F | 41 | PNET | — | 26.3 | Yes, hematologic toxicity | On | Hb, PLT, WBC | Aplasia | 34.3 |
185 | M | 74 | PNET | — | 26.4 | No | On | Hb, PLT | MDS/MPN: CMML-1 | 63.6 |
158 | M | 62 | NET | Cold octreotide | 22.2 | Yes, maximum kidney dose | Off | Hb, PLT, WBC | MDS, RAEB-II | 15.4 |
102 | M | 68 | NET | — | 30.0 | no | On | Hb, PLT, WBC | MDS, hypocellular | 20.2 |
91 | F | 59 | NET | Cold octreotide, local EBRT | 22.7 | Yes, maximum kidney dose | On | Hb, PLT, WBC | AML | 83.5 |
81 | F | 58 | NET | Cold octreotide | 22.3 | Yes, maximum kidney dose | On | Hb, PLT, WBC | Myelofibrosis/MPN | 40.8 |
PNET = pancreatic NET; EBRT = external-beam radiotherapy; Hb = hemoglobin; PLT = platelets; WBC = white blood cells; RARS = refractory anemia with ringed sideroblasts; CML = chronic myeloid leukemia; RAEB = refractory anemia with excess blasts; CMML = chronic myelomonocytic leukemia.